Sartorius Stedim Biotech S.A. Website

Sartorius Stedim Biotech S.A.

ENXTPA-DIM

Basic

  • Market Cap

    €17.39B

  • EV

    €19.92B

  • Shares Out

    97.31M

  • Revenue

    €2,716.3M

  • Employees

    10,493

Margins

  • Gross

    43.5%

  • EBITDA

    23.41%

  • Operating

    15.64%

  • Pre-Tax

    12.13%

  • Net

    9.38%

  • FCF

    6.23%

Returns (5Yr Avg)

  • ROA

    13.46%

  • ROTA

    38.58%

  • ROE

    25.73%

  • ROCE

    26.32%

  • ROIC

    17.59%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €248.83

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €695.1M

  • Net Debt

    €2,493.7M

  • Debt/Equity

    0.82

  • EBIT/Interest

    2.96

Growth (CAGR)

  • Rev 3Yr

    8.22%

  • Rev 5Yr

    16.35%

  • Rev 10Yr

    16.22%

  • Dil EPS 3Yr

    -14.15%

  • Dil EPS 5Yr

    2.35%

  • Dil EPS 10Yr

    13.96%

  • Rev Fwd 2Yr

    9.48%

  • EBITDA Fwd 2Yr

    15.75%

  • EPS Fwd 2Yr

    17.22%

  • EPS LT Growth Est

    26%

Dividends

  • Yield

  • Payout

    20.53%

  • DPS

    €0.69

  • DPS Growth 3Yr

    0.49%

  • DPS Growth 5Yr

    3.9%

  • DPS Growth 10Yr

    13.18%

  • DPS Growth Fwd 2Yr

    -20.68%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

1,440.6

1,910.1

2,887

3,492.7

2,775.5

2,716.3

Total Revenues % Chg.

18.8%

32.6%

51.1%

21%

-20.5%

-19.1%

Cost of Goods Sold, Total

692.3

906.8

1,334

1,675.4

1,542

1,534.6

Gross Profit

748.3

1,003.3

1,553

1,817.3

1,233.5

1,181.7

Selling General & Admin Expenses, Total

317.6

391.8

531.9

612.3

617.8

625.2

R&D Expenses

79.2

84.5

110.5

132.4

129.5

128.6

Other Operating Expenses

3.5

23.9

-9.6

18.2

17.5

3

Other Operating Expenses, Total

400.4

500.2

632.8

762.9

764.8

756.8

Operating Income

347.9

503.1

920.2

1,054.4

468.7

424.9

Interest Expense, Total

-3.9

-6.5

-10.2

-18.2

-115.4

-143.7

Interest And Investment Income

0.3

0.5

0.3

0.5

6.2

6.5

Net Interest Expenses

-3.5

-6

-9.9

-17.7

-109.2

-137.2

Currency Exchange Gains (Loss)

-11.7

-14.7

12.3

-32.8

-18.6

-18.6

Other Non Operating Income (Expenses)

1.5

1.1

-37.1

-4.6

0.6

0.8

EBT, Excl. Unusual Items

334.2

483.6

885.5

999.3

341.5

269.9

Restructuring Charges

Merger & Related Restructuring Charges

-0.3

-4.3

-20.3

Other Unusual Items

-16.5

-18.6

-218.5

131.1

59.6

59.6

EBT, Incl. Unusual Items

317.4

460.7

646.7

1,130.4

401.1

329.5

Income Tax Expense

81.4

122.1

232.4

250.5

89

71.9

Earnings From Continuing Operations

236

338.6

414.3

879.9

312.1

257.6

Minority Interest

-1.5

-2.7

0.1

-3.8

-2.4

-2.9

Net Income

234.5

335.9

414.4

876.1

309.7

254.7

Net Income to Common Incl Extra Items

234.5

335.9

414.4

876.1

309.7

254.7

Net Income to Common Excl. Extra Items

234.5

335.9

414.4

876.1

309.7

254.7

Total Shares Outstanding

92.2

92.2

92.2

92.2

92.2

96.7

Weighted Avg. Shares Outstanding

92.2

92.2

92.2

92.2

92.2

93.4

Weighted Avg. Shares Outstanding Dil

92.2

92.2

92.2

92.2

92.2

93.4

EPS

2.5

3.6

4.5

9.5

3.4

2.7

EPS Diluted

2.5

3.6

4.5

9.5

3.4

2.7

EBITDA

401.5

577.3

1,031.4

1,196.9

657.8

635.8

Effective Tax Rate

25.6%

26.5%

35.9%

22.2%

22.2%

21.8%